Agenus Inc., a medical-phase biotechnology corporation, discovers and develops therapies to activate the human body's immune system in opposition to cancer and infections in the United States and internationally. It offers Retrocyte Exhibit, an antibody expression platform for that identification of thoroughly human and humanized monoclonal antibod